Amicus Therapeutics Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of next-generation medicines.
| Website: | www.amicusrx.com |
| Email: | ir@amicustherapeutics.com |
| Main Phone: | +1 609 662-2000 |
| Address: | 1 Cedar Brook Drive |
| State: | NJ |
| City / Town: | Cranbury |
| Country: | USA |
| Postal Code: | 08512 |
| Exchange: | NSD |
| CEO: | John F. Crowley |
| Employees: | 325 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
| Last Price 12.21 | Change $ -0.41 | Change % -3.25 | Tick N/A |
| Bid 11.85 | Bid Size 10,000.00 | Ask 12.26 | Ask Size 300.00 |
| Open 12.53 | High 12.75 | Low 11.85 | Prev Close 12.62 |
| Last Trade | Volume 5.7 mi | 52 Wk Hi 17.62 | 52 Wk Low 11.57 |
| Market Cap 2.3 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 189,134,863.00 | EPS (TTM) -1.71 | PE Ratio N/A | Exchange NSD |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 22 | 110 |
| Number of Buys | 13 | 61 |
| Number of Sells | 9 | 49 |
| Net Activity | -78433 | 2199222 |
| Last 10 Buys | Shares |
|---|---|
| Edelman Joseph | 1,000 |
| Edelman Joseph | 1,000 |
| Edelman Joseph | 1,000 |
| Edelman Joseph | 1,000 |
| Ellen S. Rosenberg | 1,000 |
| Margaret G. McGlynn | 1,000 |
| Edelman Joseph | 1,000 |
| Edelman Joseph | 1,000 |
| Edelman Joseph | 1,000 |
| Edelman Joseph | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Hung Do | 1,000 |
| Hung Do | 1,000 |
| Margaret G. McGlynn | 1,000 |
| Jay Barth | 1,000 |
| Hung Do | 1,000 |
| Michael G. Raab | 1,000 |
| Jay Barth | 1,000 |
| Kurt J. Andrews | 1,000 |
| William D. Baird | 1,000 |
| Jay Barth | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 22 | 22 | 22 | 22 |
| Low Target Price Estimate | 18.5 | 18.5 | 18.5 | 18.5 |
| Mean Target Price Estimate | 20.08 | 20.08 | 20.08 | 20.08 |
| Standard Deviation | 1.56 | 1.56 | 1.56 | 1.56 |
| Date of Most Recent Estimate | 05/11/18 | 05/11/18 | 05/11/18 | 05/11/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-11 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-11 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-11 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-11 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-11 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-11 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-11 |
| 8-K | Report of unscheduled material events or corporate changes. | 21 | 2018-06-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-04 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-18 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
